A New Hope for ITP Patients: Rilzabrutinib Shows Promise
Chronic Immune Thrombocytopenia (ITP) is a condition where the body's immune system attacks and destroys platelets, leading to excessive bleeding and bruising. Patients with ITP often struggle with low platelet counts and the need for frequent rescue therapies. A recent study, LUNA3, focus